BODY_HEALTH_GROUP_LTD - Accounts


Company registration number 12898698 (England and Wales)
BODY HEALTH GROUP LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2023
PAGES FOR FILING WITH REGISTRAR
BODY HEALTH GROUP LTD
CONTENTS
Page
Balance sheet
1
Statement of changes in equity
2
Notes to the financial statements
3 - 6
BODY HEALTH GROUP LTD
BALANCE SHEET
AS AT
30 SEPTEMBER 2023
30 September 2023
- 1 -
2023
2022
Notes
£
£
£
£
Fixed assets
Investments
4
8,040
26,800
Current assets
Debtors
5
1,520
1,520
Cash at bank and in hand
2,952
815
4,472
2,335
Creditors: amounts falling due within one year
6
(60,247)
(45,881)
Net current liabilities
(55,775)
(43,546)
Net liabilities
(47,735)
(16,746)
Capital and reserves
Called up share capital
7
20
20
Profit and loss reserves
(47,755)
(16,766)
Total equity
(47,735)
(16,746)

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 30 September 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 19 June 2024 and are signed on its behalf by:
Mr B J Van Rooyen
Director
Company registration number 12898698 (England and Wales)
BODY HEALTH GROUP LTD
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 30 SEPTEMBER 2023
- 2 -
Share capital
Profit and loss reserves
Total
£
£
£
Balance at 1 October 2021
-
0
(7,217)
(7,217)
Year ended 30 September 2022:
Loss for the year
-
(9,549)
(9,549)
Issue of share capital
20
-
20
Balance at 30 September 2022
20
(16,766)
(16,746)
Year ended 30 September 2023:
Loss for the year
-
(30,989)
(30,989)
Balance at 30 September 2023
20
(47,755)
(47,735)
BODY HEALTH GROUP LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2023
- 3 -
1
Accounting policies
Company information

Body Health Group Ltd is a private company limited by shares incorporated in England and Wales. The registered office is 38 Watermill Lane, Hertford, SG14 3LB.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

As at the balance sheet date, the financial statements show that the company has liabilities in excess of assets of £47,735true as a result of losses made to date. The financial statements have been prepared on a going concern basis as the company's sole director and shareholder has confirmed that he will continue to support the company for foreseeable future and meet the excess liabilities if the company is unable to do so.

1.3
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

1.4
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

1.5
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand and deposits held at call with bank.

1.6
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

BODY HEALTH GROUP LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2023
1
Accounting policies
(Continued)
- 4 -
Basic financial assets

Basic financial assets, which include trade and other debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including trade and other creditors, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.7
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

 

The key judgement made in the preparation of these financial statements has been the director's estimate of the proceeds that will ultimately be receivable from the investment disposal in the year (see note 4)

3
Employees

The company had 0 employees during the current or prior year.

BODY HEALTH GROUP LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2023
- 5 -
4
Fixed asset investments
2023
2022
£
£
Shares in group undertakings and participating interests
8,040
26,800
Movements in fixed asset investments
Shares in group undertakings
£
Cost or valuation
At 1 October 2022
26,800
Disposals
(18,760)
At 30 September 2023
8,040
Impairment
At 1 October 2022 & 30 September 2023
-
Carrying amount
At 30 September 2023
8,040
At 30 September 2022
26,800
The company's investment comprises a 20% (2022: 67%) interest in the ordinary share capital of Balance VA Ltd, a company incorporated in England and Wales that provides virtual assistance for the chiropractic industry, with registered office at Node Enterprise Road, Roundswell, Barnstaple, England, EX31 3YB.
5
Debtors
2023
2022
Amounts falling due within one year:
£
£
Amounts owed by group undertakings
1,500
1,500
Other debtors
20
20
1,520
1,520
6
Creditors: amounts falling due within one year
2023
2022
£
£
Other creditors
60,247
45,881
BODY HEALTH GROUP LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2023
- 6 -
7
Called up share capital
2023
2022
2023
2022
Ordinary share capital
Number
Number
£
£
Issued and not fully paid
Ordinary shares of 1p each
2,000
2,000
20
20
8
Related party transactions

Included within other creditors is a balance of £58,740 (2022: £43,063) owed to a director. The loan is interest free and repayable on demand.

 

At the balance sheet date, £1,500 (2022: £1,500) was owed by Balance VA Limited, a group undertaking.

2023-09-302022-10-01false19 June 2024CCH SoftwareCCH Accounts Production 2024.100No description of principal activityMr O S CodringtonMr B J Van Rooyenfalsefalse128986982022-10-012023-09-30128986982023-09-30128986982022-09-3012898698core:CurrentFinancialInstrumentscore:WithinOneYear2023-09-3012898698core:CurrentFinancialInstrumentscore:WithinOneYear2022-09-3012898698core:ShareCapital2023-09-3012898698core:ShareCapital2022-09-3012898698core:RetainedEarningsAccumulatedLosses2023-09-3012898698core:RetainedEarningsAccumulatedLosses2022-09-3012898698core:ShareCapital2021-09-3012898698core:RetainedEarningsAccumulatedLosses2021-09-30128986982021-09-3012898698bus:Director22022-10-012023-09-3012898698core:RetainedEarningsAccumulatedLosses2021-10-012022-09-30128986982021-10-012022-09-3012898698core:RetainedEarningsAccumulatedLosses2022-10-012023-09-3012898698core:ShareCapital2021-10-012022-09-3012898698core:CurrentFinancialInstruments2022-09-3012898698core:WithinOneYear2023-09-3012898698core:WithinOneYear2022-09-3012898698core:CurrentFinancialInstruments2023-09-3012898698bus:PrivateLimitedCompanyLtd2022-10-012023-09-3012898698bus:SmallCompaniesRegimeForAccounts2022-10-012023-09-3012898698bus:FRS1022022-10-012023-09-3012898698bus:AuditExemptWithAccountantsReport2022-10-012023-09-3012898698bus:Director12022-10-012023-09-3012898698bus:FullAccounts2022-10-012023-09-30xbrli:purexbrli:sharesiso4217:GBP